Human papilloma virus-16/18 cervical infection among women attending a family medical clinic in Riyadh

Annals of Saudi Medicine

Volumn 27, Issue 1, 2007, Pages 1-5

  Al Muammar, Tarfah ^a   Al Ahdal, Mohammed N ^a   Hassan, Ahmed ^a   Kessie, George ^a,b   Dela Cruz, Damian M ^a   Mohamed, Gamal E ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Gene Logic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARAB; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; FAMILY MEDICINE; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HEALTH CARE FACILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAUDI ARABIA; SOUTHERN BLOTTING; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 34147204251     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2007.1     Document Type: Article

References (26)

1. Liaw KL, Glass AG, Manos MM, Greer CE, Scott DR, Sherman M, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst 1999; 91: 954-960.
2. Olsen AO, Gjoen K, Sauer T, Orstavik I, Naess O, Kierulf K, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: A popoulation-based case-control study. Int J Cancer 1995; 61: 312-315.
3. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000; 86: 429-435.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kurmmer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
5. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002; 20: 1080-1085.
6. Oh YL, Shin KJ, Han J, Kim DS. Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening. Cytopathology 2001; 12: 75-83.
7. Richart RM, Masood S, Syrjanen KJ, Vassilakos P, Kaufman RH, Meisels A, at al. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998; 42: 50-58.
8. Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA 2000; 283: 108-109.
9. Al-Ahdal MN, Kardar AH, Selim AM, Kessie G. Occurrence of human papillomavirus types 16 and 18 in benign prostatic hyperplasia tissues of Saudi patients. Genitourin Med 1996; 72: 345-346.
10. McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. J Urol 1991; 145: 850-853.
11. Burk RD. Human papillomavirus and the risk of cervical cancer. Hosp Pract 1999; 34: 103-111.
12. Molano M, Posso H, Weiderpass E, van der Brule AJC, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002; 87: 324-333.
13. Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, at al. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol 2002; 86: 157-162.
14. Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, at al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998; 70: 115-120.
15. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002; 23: 429-432.
16. Forslund O, Antonsson A, Edlund K, van der Brule AJ, Hansson BG, Meijer CJ, et al. Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol 2002; 66: 535-541.
17. Tidy JA, Parry GC, Ward P, Coleman DV, Peto J, Malcolm AD, et al. High rate of human papillomavirus type 16 infection in cytologically normal cervices. Lancet 1989; 1: 434.
18. Lambropoulos AF, Agorastos T, Frangoulides E, Karahaliou R, Bontis J, Dozi-Vassiliades I. Detection of human papillomavirus using the polymerase chain reaction and typing for HPV 16 and 18 in the cervical smear of Greek women. J Med Virol 1994; 43: 228-230.
19. Tachezy R, Hamsikova E, Hajek T, Mikyskova I, Smahel M, Van Ranst M, et al. Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol 1999; 58: 378-386.
20. Brown DR, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 2002; 29: 763-768.
21. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Nat Cancer Inst 1995; 87: 796-802.
22. Zazove P, Reed BD, Gregoire L, Ferenczy A, Gorenflo DW, Lancaster WD. Low false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions. J Clin Microbiol 1998; 36: 2708-2713.
23. Mohamed M. Cervical Cancer Screening Program in Saudi Arabia: Action is Overdue. Ann Saudi Med 2000; 20: 355-357.
24. Katase K, Teshima H, Hirai Y, Hasumi K. Natural history of cervical human papillomavirus lesions. Intervirology 1995; 38: 192-194.
25. Schultz J. Success of vaccine offers promise of cervical cancer prevention. J Natl Cancer Inst 2003; 95: 102-104.
26. Speck LM, Tyring SK. Vaccines for the prevention of human papillomavirus infections. Skin Therapy Lett 2006; 11: 1-3.